{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CLPT/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T16:00:20.496Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":10470,"canonical_name":"ClearPoint Neuro, Inc.","cik":"0001285550","uei":null,"lei":null,"duns":null,"ticker":"CLPT"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":55},"count":55,"timeline":[{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — ClearPoint Neuro, Inc. — 2026-10-02","url_slug":"/sec/cik-0001285550/4/0001193125-26-412434","accession_number":"0001193125-26-412434","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — ClearPoint Neuro, Inc. — 2026-09-03","url_slug":"/sec/cik-0001285550/4/0001193125-26-382208","accession_number":"0001193125-26-382208","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — ClearPoint Neuro, Inc. — 2026-08-12","url_slug":"/sec/cik-0001285550/schedule-13g-a/0001385702-26-000004","accession_number":"0001385702-26-000004","importance":30},{"ts":"2026-08-04","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — ClearPoint Neuro, Inc. — 2026-08-04","url_slug":"/sec/cik-0001285550/schedule-13g-a/0000921895-26-001945","accession_number":"0000921895-26-001945","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"10-Q","title":"10-Q — ClearPoint Neuro, Inc. — 2026-08-03","url_slug":"/sec/cik-0001285550/10-q/0001193125-26-330842","accession_number":"0001193125-26-330842","importance":45},{"ts":"2026-08-03","kind":"sec.filing","form_type":"8-K","title":"8-K — ClearPoint Neuro, Inc. — 2026-08-03","url_slug":"/sec/cik-0001285550/8-k/0001193125-26-330541","accession_number":"0001193125-26-330541","importance":35},{"ts":"2026-07-27","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — ClearPoint Neuro, Inc. — 2026-07-27","url_slug":"/sec/cik-0001285550/schedule-13g-a/0002012383-26-002234","accession_number":"0002012383-26-002234","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"4","title":"4 — ClearPoint Neuro, Inc. — 2026-07-06","url_slug":"/sec/cik-0001285550/4/0001193125-26-296614","accession_number":"0001193125-26-296614","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — ClearPoint Neuro, Inc. — 2026-07-02","url_slug":"/sec/cik-0001285550/4/0001193125-26-294474","accession_number":"0001193125-26-294474","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — ClearPoint Neuro, Inc. — 2026-07-02","url_slug":"/sec/cik-0001285550/4/0001193125-26-294476","accession_number":"0001193125-26-294476","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — ClearPoint Neuro, Inc. — 2026-07-02","url_slug":"/sec/cik-0001285550/4/0001193125-26-294477","accession_number":"0001193125-26-294477","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — ClearPoint Neuro, Inc. — 2026-07-01","url_slug":"/sec/cik-0001285550/4/0001193125-26-292932","accession_number":"0001193125-26-292932","importance":30},{"ts":"2026-07-01","kind":"sec.insider.a","reporter":"FLETCHER R JOHN","title":null,"shares":662,"price_per_share":17.84,"usd_value":11810,"security_title":"Common Stock","importance":15.01181008},{"ts":"2026-07-01","kind":"sec.insider.a","reporter":"Richards Timothy T.","title":null,"shares":222,"price_per_share":17.84,"usd_value":3960,"security_title":"Common Stock","importance":15.00396048},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"STIGALL L. JEREMY","title":"Chief Business Officer","shares":1781,"price_per_share":11.93,"usd_value":21247,"security_title":"Common Stock","importance":15.02124733},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"BURNETT JOSEPH","title":"CEO and President","shares":1361,"price_per_share":11.93,"usd_value":16237,"security_title":"Common Stock","importance":15.01623673},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"D'Alessandro Danilo","title":"Chief Financial Officer","shares":1085,"price_per_share":11.93,"usd_value":12944,"security_title":"Common Stock","importance":15.01294405},{"ts":"2026-06-29","kind":"sec.form144","reporter":"JOSEPH BURNETT","title":"Director, Officer","shares":20000,"usd_value":369600,"security_title":"Common","approx_sale_date":"2026-06-29","accession_number":"0001950047-26-006598","importance":40.07392},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"BURNETT JOSEPH","title":"CEO and President","shares":20000,"price_per_share":19.38,"usd_value":387600,"security_title":"Common Stock","importance":35.3876},{"ts":"2026-06-29","kind":"sec.filing","form_type":"144","title":"144 — ClearPoint Neuro, Inc. — 2026-06-29","url_slug":"/sec/cik-0001285550/144/0001950047-26-006598","accession_number":"0001950047-26-006598","importance":30},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"BURNETT JOSEPH","title":"CEO and President","shares":20000,"price_per_share":2.5,"usd_value":50000,"security_title":"Common Stock","importance":15.05},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — ClearPoint Neuro, Inc. — 2026-06-22","url_slug":"/sec/cik-0001285550/4/0001193125-26-277503","accession_number":"0001193125-26-277503","importance":30},{"ts":"2026-06-17","kind":"sec.form144","reporter":"JOSEPH BURNETT","title":"Director, Officer","shares":60000,"usd_value":800400,"security_title":"Common","approx_sale_date":"2026-06-17","accession_number":"0001950047-26-006271","importance":40.16008},{"ts":"2026-06-17","kind":"sec.form144","reporter":"JOSEPH M BURNETT TRUST","title":"Affiliate of Director","shares":1843,"usd_value":24586,"security_title":"Common","approx_sale_date":"2026-06-17","accession_number":"0001950047-26-006274","importance":40.004917124},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"BURNETT JOSEPH","title":"CEO and President","shares":60000,"price_per_share":17.79,"usd_value":1067400,"security_title":"Common Stock","importance":36.0674},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"BURNETT JOSEPH","title":"CEO and President","shares":1843,"price_per_share":17.94,"usd_value":33063,"security_title":"Common Stock","importance":35.03306342},{"ts":"2026-06-17","kind":"sec.filing","form_type":"144","title":"144 — ClearPoint Neuro, Inc. — 2026-06-17","url_slug":"/sec/cik-0001285550/144/0001950047-26-006271","accession_number":"0001950047-26-006271","importance":30},{"ts":"2026-06-17","kind":"sec.filing","form_type":"144","title":"144 — ClearPoint Neuro, Inc. — 2026-06-17","url_slug":"/sec/cik-0001285550/144/0001950047-26-006274","accession_number":"0001950047-26-006274","importance":30},{"ts":"2026-06-17","kind":"sec.insider.m","reporter":"BURNETT JOSEPH","title":"CEO and President","shares":60000,"price_per_share":2.5,"usd_value":150000,"security_title":"Common Stock","importance":15.15},{"ts":"2026-06-08","kind":"sec.filing","form_type":"4","title":"4 — ClearPoint Neuro, Inc. — 2026-06-08","url_slug":"/sec/cik-0001285550/4/0001193125-26-261835","accession_number":"0001193125-26-261835","importance":30},{"ts":"2026-06-04","kind":"sec.insider.f","reporter":"Richards Timothy T.","title":null,"shares":376,"price_per_share":13.3,"usd_value":5001,"security_title":"Common Stock","importance":15.0050008},{"ts":"2026-06-04","kind":"sec.insider.m","reporter":"Richards Timothy T.","title":null,"shares":500,"price_per_share":10,"usd_value":5000,"security_title":"Common Stock","importance":15.005},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — ClearPoint Neuro, Inc. — 2026-06-02","url_slug":"/sec/cik-0001285550/4/0001193125-26-253602","accession_number":"0001193125-26-253602","importance":30},{"ts":"2026-06-01","kind":"sec.form144","reporter":"TIMOTHY RICHARDS","title":"Director","shares":5145,"usd_value":62612,"security_title":"Common","approx_sale_date":"2026-06-01","accession_number":"0001950047-26-005346","importance":40.012522312},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Richards Timothy T.","title":null,"shares":5415,"price_per_share":12.17,"usd_value":65901,"security_title":"Common Stock","importance":35.06590055},{"ts":"2026-06-01","kind":"sec.filing","form_type":"144","title":"144 — ClearPoint Neuro, Inc. — 2026-06-01","url_slug":"/sec/cik-0001285550/144/0001950047-26-005346","accession_number":"0001950047-26-005346","importance":30},{"ts":"2026-05-21","kind":"sec.form144","reporter":"MATTHEW B KLEIN","title":"Director","shares":16000,"usd_value":185392,"security_title":"Common","approx_sale_date":"2026-05-21","accession_number":"0001950047-26-004887","importance":40.0370784},{"ts":"2026-05-21","kind":"sec.filing","form_type":"8-K","title":"8-K — ClearPoint Neuro, Inc. — 2026-05-21","url_slug":"/sec/cik-0001285550/8-k/0001193125-26-234571","accession_number":"0001193125-26-234571","importance":35},{"ts":"2026-05-21","kind":"sec.filing","form_type":"144","title":"144 — ClearPoint Neuro, Inc. — 2026-05-21","url_slug":"/sec/cik-0001285550/144/0001950047-26-004887","accession_number":"0001950047-26-004887","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"4","title":"4 — ClearPoint Neuro, Inc. — 2026-05-21","url_slug":"/sec/cik-0001285550/4/0001193125-26-234562","accession_number":"0001193125-26-234562","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"4","title":"4 — ClearPoint Neuro, Inc. — 2026-05-21","url_slug":"/sec/cik-0001285550/4/0001193125-26-234565","accession_number":"0001193125-26-234565","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"4","title":"4 — ClearPoint Neuro, Inc. — 2026-05-21","url_slug":"/sec/cik-0001285550/4/0001193125-26-234570","accession_number":"0001193125-26-234570","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"4","title":"4 — ClearPoint Neuro, Inc. — 2026-05-21","url_slug":"/sec/cik-0001285550/4/0001193125-26-234577","accession_number":"0001193125-26-234577","importance":30},{"ts":"2026-05-20","kind":"sec.form144","reporter":"LYNNETTE C FALLON","title":"Director","shares":5091,"usd_value":56866,"security_title":"Common","approx_sale_date":"2026-05-20","accession_number":"0001950047-26-004856","importance":40.011373294},{"ts":"2026-05-20","kind":"sec.insider.s","reporter":"FALLON LYNNETTE C","title":null,"shares":5091,"price_per_share":11.14,"usd_value":56714,"security_title":"Common Stock","importance":35.05671374},{"ts":"2026-05-19","kind":"sec.insider.m","reporter":"FALLON LYNNETTE C","title":null,"shares":12417,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-19","kind":"sec.insider.m","reporter":"FLETCHER R JOHN","title":null,"shares":12417,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-19","kind":"sec.insider.m","reporter":"JOHNSON B KRISTINE","title":null,"shares":12417,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-19","kind":"sec.insider.m","reporter":"LIAU LINDA M.","title":null,"shares":12417,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-19","kind":"sec.insider.m","reporter":"Richards Timothy T.","title":null,"shares":12417,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-19","kind":"sec.insider.m","reporter":"Girin Pascal E R","title":null,"shares":12417,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-19","kind":"sec.insider.m","reporter":"Klein Matthew B.","title":null,"shares":12417,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — ClearPoint Neuro, Inc. — 2026-05-15","url_slug":"/sec/cik-0001285550/schedule-13g-a/0001426156-26-000011","accession_number":"0001426156-26-000011","importance":30},{"ts":"2026-05-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — ClearPoint Neuro, Inc. — 2026-05-13","url_slug":"/sec/cik-0001285550/10-q/0001193125-26-221890","accession_number":"0001193125-26-221890","importance":45},{"ts":"2026-05-13","kind":"sec.filing","form_type":"8-K","title":"8-K — ClearPoint Neuro, Inc. — 2026-05-13","url_slug":"/sec/cik-0001285550/8-k/0001193125-26-221596","accession_number":"0001193125-26-221596","importance":35}]}